4DMedical and Imbio Merge to Create Comprehensive Cardiothoracic Image Analysis Portfolio
4DMedical announces it has entered a binding agreement to acquire Imbio (a portfolio company of Minneapolis-based Invenshure). As the creators of groundbreaking lung imaging technologies, 4DMedical aims to revolutionize respiratory imaging and ventilation— for improved lung disease detection and management. Imbio technology complements those products perfectly, delivering quantitative and personalized imaging analysis for patients suffering from both acute and chronic diseases.
A Clinician’s Guide to Occupational Exposures in the Military
Purpose of Review Adverse occupational and environmental exposures are common causes of respiratory disease and health consequences requiring medical care. Understanding how these various exposures affect patients and how to elicit an adequate history is critical for any clinician. Military personnel are often overlooked when discussing groups at risk for environmental exposure-associated airway disease. There […]
Patient Story – Bronchiectasis
John was diagnosed with bronchiectasis at age 14. Bronchiectasis is commonly defined as a condition where damage to the lungs causes the airways to widen or develop pouches which makes it more challenging to clear out mucus, leading to frequent infections. This differs from the more common condition of bronchitis, which is a temporary illness and causes no long-term damage. According to the American Lung Association, Bronchiectasis affects 350,000 to 500,000 people in the United States.
“Advances in Functional Lung Imaging” on The Imaging Wire Show
Brian Casey of The Imaging Wire interviews 4DMedical’s MD/CEO Dr Andreas Fouras, PhD and resident radiologist Dr Greg Mogel, MD | WATCH THE VIDEO [VIDEO duration 24:53]
Dr Geraldine McGinty appointed to Board of Directors
Internationally recognised leader in health care strategy and imaging economics, Dr Geraldine McGinty has joined the 4DMedical board.
STUDY: Siddharthan, T. et al. Quantifying ventilation by X-ray velocimetry in healthy adults.
Siddharthan, T., Grealis, K., Kirkness, J.P. et al. Quantifying ventilation by X-ray velocimetry in healthy adults. Respir Res 24, 215 (2023). https://doi.org/10.1186/s12931-023-02517-z
NEWS: 4DMedical releases Full Year Results and Annual Report
Fy2022-23 Full Year Results, Appendix 4E and Annual Report available online.
Prestigious Eureka Prize win recognises 4DMedical imaging innovation
4DMedical’s unique XV Technology™ has propelled a team of medical researchers to a 2023 Eureka Prize win, announced at a ceremony in Sydney last night. The Australian Museum Eureka Prizes are the country’s most comprehensive national science awards, honouring excellence across the areas of research and innovation, leadership, science engagement and school science. The Cystic […]
EVENT: Innovation Week seminar at Melbourne Connect 5 SEP 2023
Chemical Casualties: The hidden cost of war This Innovation Week seminar at Melbourne Connect is open to the public and free of charge. Tuesday 5 September 1200-1400 including lunch; Superfloor Forum. Presented jointly by 4DMedical and CADRE-OCE — the Centre for Advanced Defence Research and Enterprise – Operating in Chemical, Biological, Radiological and Nuclear Environments. Engage in a captivating […]
NEWS: 4DMedical wins $1.1m of CTCM funding announced by Health Minister Mark Butler
4DMedical has been awarded $1.1 million of CTCM funding announced this morning by Minister for Health and Aged Care, the Hon Mark Butler, MP. This CTCM funding powered by MTPConnect will be used to further develop the capability of our XV Lung Scanner, combining both functional components of airflow and blood flow into a single analytical process […]